Skip to main content
Fig. 1 | Translational Medicine Communications

Fig. 1

From: Prevent Cancer Foundation quantitative CT imaging workshop XVI: lung cancer, COPD and cardiovascular disease - on the cusp of transformation, Arlington, VA

Fig. 1

Recently honored Andrew C. von Eschenbach, M.D., with the 2019 James L. Mulshine, M.D., Leadership Award for his work leading the National Lung Screening Trial (NLST), the first largescale clinical trial for low-dose computed tomography (CT) lung cancer screening. The award was presented on October 10, 2019, at the 16th annual Quantitative Imaging Workshop: Lung Cancer, COPD, and Cardiovascular Disease. Andrew C. von Eschenbach, M.D., receives the James L. Mulshine, M.D., Leadership Award from the Prevent Cancer Foundation. Left to right: Dr. Mulshine; Claudia Henschke, Ph.D., M.D.; Carolyn R. Aldigé; and Dr. von Eschenbach

Back to article page

Translational Medicine Communications

ISSN: 2396-832X

Contact us